895155-26-7

A-796260 is a synthetic cannabinoid (CB) that shows high selectivity for the CB₂ receptor (K_i = 0.77 nM) over the CB₁ receptor (K_i = 2,100 nM). It also shows efficacy in vivo in models of inflammatory, post-operative, neuropathic, and osteoarthritic pain, activities which are selectively blocked by CB₂ receptor-selective antagonists. This product is intended for research and forensic uses.

A-796,260 is a synthetic cannabinoid that shows high selectivity towards CB2 receptor over the CB1 receptor. A-796,260 showed high efficacy in models of inflammatory, post-operative, neuropathic and OA pain in vivo.